Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8(+) T-cell recall responses

Blood. 2013 Mar 28;121(13):2432-9. doi: 10.1182/blood-2012-06-438481. Epub 2013 Jan 16.

Abstract

Rapid boosting of memory CD8(+) T cells (TM) is essential in cancer immunotherapy and the control of certain infectious diseases. However, effector T cells (TE) are a barrier to booster vaccination because they can rapidly kill antigen-bearing antigen-presenting cells (APCs) before TM are engaged. We demonstrate that viral-vectored vaccines delivered by B cells elicit robust TM expansion in the presence of TE, enabling booster immunizations to bypass TE-mediated negative feedback regulation. Our data indicate that viral vector-loaded B cells home to the follicular regions in secondary lymphoid organs, which are anatomically separated from TE and in close proximity to TM. The B cells, however, do not serve as APCs in this area. Rather, classic CD11c(+) dendritic cells serve to stimulate the secondary CD8(+) T-cell response. Our data reveal that B cells represent a novel and readily accessible delivery system that can effectively engage secondary CD8(+) T-cell activation for prime-boost strategies.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acceleration
  • Adenoviridae* / genetics
  • Animals
  • B-Lymphocytes / metabolism
  • B-Lymphocytes / transplantation*
  • CD8-Positive T-Lymphocytes / immunology*
  • Cells, Cultured
  • Gene Transfer Techniques
  • Genetic Vectors / administration & dosage*
  • Immunization, Secondary / methods
  • Immunologic Memory* / genetics
  • Immunotherapy, Adoptive / methods*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Vaccination / methods